Particle.news
Public Health Patient Care Pharmaceuticals Mental Health Emergency Services Cancer Medical Research Clinical Trials NHS Reproductive Health Research Infectious Diseases Medical Professionals Health Insurance Medical Conditions Patient Safety Vaccination Clinical Research Insurance Epidemiology Surgery Women's Health Medical Ethics Medicare Medical Procedures Medical Technology Injuries Preventive Medicine Cancer Treatment Vaccines Pediatric Care Preventive Care Neurology Pediatrics Medical Treatments Chronic Diseases Health Policy Emergency Care Hospitals Disease Prevention Hospital Management Emergency Medicine Hospitalization Maternal Health Chronic Conditions Diseases Regulatory Affairs Nursing Medical Treatment Medications Emergency Response Cancer Research Obesity Child Health Treatment Medical Services Nutrition Patient Advocacy Patient Experience Medical Education Patient Rights Pharmacology Healthcare Policy Chronic Illness Medical Devices Public Health Policy Medical Facilities Patient Outcomes Healthcare Workers Drug Development Healthcare Systems Research Studies Medicaid Oncology Transgender Health Palliative Care Statistics Gender-Affirming Care Patient Education Aging Regulatory Agencies Treatment Options End-of-Life Care Hospital Services Elderly Care Access to Care Organ Donation Humanitarian Aid Hospital Administration Diagnosis Policy Primary Care Global Health Cardiology Substance Abuse Maternity Care Pharmacy Transplantation Biotechnology Medicine
The BiVACOR Total Artificial Heart kept the patient alive for over 100 days before a successful heart transplant, marking a milestone in medical innovation.
